Literature DB >> 21206246

Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression.

Ho-Jun Seo1, Young-Eun Jung, Tae-Suk Kim, Jung-Bum Kim, Min-Soo Lee, Jae-Min Kim, Hyun-Woo Lim, Tae-Youn Jun.   

Abstract

This study evaluated clinical characteristics and suicidality of patients with anxious depression in a large cohort of samples. Data were collected from 1003 patients who were depressed. A total of 461 patients were diagnosed with anxious depression and 542 were diagnosed with nonanxious depression. After adjusting for the severity of depression, those in the anxious depression group had significantly younger onset age, had been suffering from depression for a longer period, were more likely to experience a recurrence, and obtained lower scores on a scale assessing quality of life. The anxious depression group was characterized by a significantly higher proportion of individuals reporting significant suicidal ideation and previous suicide attempts, and those in this group tended to obtain higher scores on the Scale for Suicide Ideation. The present findings that were drawn from detailed evaluation of suicidality strongly support previous results assessed only with the help of clinical reports. More attention should be paid to assess suicide risk in these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21206246     DOI: 10.1097/NMD.0b013e3182043b60

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

1.  Treatment Emergent Suicidal Ideation in depressed older adults.

Authors:  Pilar Cristancho; Brendan O'Connor; Eric J Lenze; Daniel M Blumberger; Charles F Reynolds; David Dixon; Benoit H Mulsant
Journal:  Int J Geriatr Psychiatry       Date:  2016-05-09       Impact factor: 3.485

Review 2.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Authors:  Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

3.  Ziprasidone augmentation for anxious depression.

Authors:  Dawn F Ionescu; Richard C Shelton; Lee Baer; Kathryn H Meade; Michaela B Swee; Maurizio Fava; George I Papakostas
Journal:  Int Clin Psychopharmacol       Date:  2016-11       Impact factor: 1.659

4.  Anxious depression as a clinically relevant subtype of pediatric major depressive disorder.

Authors:  Isabelle Häberling; Noemi Baumgartner; Sophie Emery; Paola Keller; Michael Strumberger; Kristin Nalani; Klaus Schmeck; Suzanne Erb; Silke Bachmann; Lars Wöckel; Ulrich Müller-Knapp; Brigitte Contin-Waldvogel; Bruno Rhiner; Susanne Walitza; Gregor Berger
Journal:  J Neural Transm (Vienna)       Date:  2019-08-27       Impact factor: 3.575

Review 5.  Investigating the nature of co-occurring depression and anxiety: Comparing diagnostic and dimensional research approaches.

Authors:  Katharina Kircanski; Joelle LeMoult; Sarah Ordaz; Ian H Gotlib
Journal:  J Affect Disord       Date:  2016-08-13       Impact factor: 4.839

Review 6.  Neurobiology of anxious depression: a review.

Authors:  Dawn F Ionescu; Mark J Niciu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

7.  Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Authors:  Aldemara I Silva; Victor A D Holanda; Joaquim G Azevedo Neto; Edilson D Silva Junior; Vanessa P Soares-Rachetti; Girolamo Calo; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

Review 8.  Defining anxious depression: a review of the literature.

Authors:  Dawn F Ionescu; Mark J Niciu; Ioline D Henter; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-14       Impact factor: 3.790

9.  Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.

Authors:  Michelle S Parris; Julia E Marver; Sadia R Chaudhury; Steven P Ellis; Allison V Metts; John G Keilp; Ainsley K Burke; Maria A Oquendo; Joseph J Mann; Michael F Grunebaum
Journal:  Int Clin Psychopharmacol       Date:  2018-09       Impact factor: 1.659

10.  Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study.

Authors:  Pratap Chokka; Holly Ge; Joanna Bougie; Anders Ettrup; Guerline Clerzius
Journal:  Ther Adv Psychopharmacol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.